Experiments for taxon Streptomyces galilaeus (STREPTOMYCETACEAE)

Experiments (25 results)

Filters
Worktypes (16)
14
9
8
7
4
4
3
2
2
2
1
1
1
1
1
1
No match
Pharmacology (9)
7
2
1
1
1
1
1
1
10
No match
Compounds (23)
16
5
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
No match
Organisms (9)
10
5
2
2
2
1
1
1
1
No match
25 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
1003169
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces galilaeus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC MA-144-S-2STREPTOMYCES ANTIBIOTIC MA-144-U-1STREPTOMYCES ANTIBIOTIC MA-144-G-2STREPTOMYCES ANTIBIOTIC MA-144-U-2STREPTOMYCES ANTIBIOTIC MA-144-LSTREPTOMYCES ANTIBIOTIC MA-144-N-1STREPTOMYCES ANTIBIOTIC MA-144-G-1STREPTOMYCES ANTIBIOTIC MA-144-S-1
1029314
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces galilaeus (STREPTOMYCETACEAE)
SULFURMYCIN BSULFURMYCIN AAURAMYCIN BAURAMYCIN A
836503
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN BACLACINOMYCIN A
873973
PHARMACOLOGY OF COMPOUND - IN VITRO
RNA SYNTHESIS INHIBITION
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN A
1030172
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Streptomyces galilaeus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC MA-144-M-1
1034185
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces galilaeus (STREPTOMYCETACEAE)
SULFURMYCIN BSULFURMYCIN AAURAMYCINONE,7-DEOXY:AURAMYCIN BAURAMYCINONEAURAMYCIN ASULFURMYCINONE,7-DEOXY:
873967
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN A
1030174
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Streptomyces galilaeus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC MA-144-M-2
873970
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN A
873969
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN A
836502
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN BACLACINOMYCIN A
1030173
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Streptomyces galilaeus (STREPTOMYCETACEAE)
CINERUBIN A
873974
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN A
836506
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN BACLACINOMYCIN A
873968
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN A
873966
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN A
836505
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN BACLACINOMYCIN A
873971
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA SYNTHESIS INHIBITION
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN A
1003168
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces galilaeus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC MA-144-S-2STREPTOMYCES ANTIBIOTIC MA-144-U-1STREPTOMYCES ANTIBIOTIC MA-144-G-2STREPTOMYCES ANTIBIOTIC MA-144-U-2STREPTOMYCES ANTIBIOTIC MA-144-LSTREPTOMYCES ANTIBIOTIC MA-144-N-1STREPTOMYCES ANTIBIOTIC MA-144-G-1STREPTOMYCES ANTIBIOTIC MA-144-S-1
836504
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN BACLACINOMYCIN A
1004029
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces galilaeus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC MA-144-4
873972
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEIN SYNTHESIS INHIBITION
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN A
873965
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN A
1030171
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN A
316989
STRUCTURE DETERMINATION OFPMR SPECTRUM REPORTEDORD SPECTRUM REPORTEDABSOLUTE CONFIGURATION DETERMINEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)STEREOCHEMISTRY DETERMINED FOR
Streptomyces galilaeus (STREPTOMYCETACEAE)
AKLAVINONE IIAKLAVINONE I